Status:
UNKNOWN
Efficacy and Safety of Hydromorphone-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia
Lead Sponsor:
Maternal and Child Health Hospital of Hubei Province
Conditions:
Analgesia
Labor Pain
Eligibility:
FEMALE
20-40 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare the effects of three different doses of hydromorphone combined with ropivacaine and sufentanil combined with ropivacaine in epidural labor analgesia through pro...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) physical status II
- a single fetus
- competent to provide informed consent
Exclusion
- severe respiratory diseases including hypoxemia, respiratory failure and severe pneumonia
- severe circulatory diseases including acute decompensated heart failure and peripartum cardiomyopathy
- placenta previa
Key Trial Info
Start Date :
September 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 17 2023
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06036797
Start Date
September 17 2023
End Date
October 17 2023
Last Update
October 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maternal and Child Health Hospital of Hubei Province
Wuhan, Hubei, China, 430000